BNB Plus Corp. earnings releases BNBX

BNB Plus Corp. last reported quarterly results on Aug 14, 2025, for Q3 FY2025 (the quarter ended Jun 30, 2025): revenue of $304,393 (-35.6% year over year) and diluted EPS of -$34.00. It usually reports 39–45 days after a quarter ends.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 39–45 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Aug 14, 2025
45 days after quarter end
Q3 FY2025
ended Jun 30, 2025
0
-35.6%
-4
-309.9%
-34.00
-102.9%
May 15, 2025
45 days after quarter end
Q2 FY2025
ended Mar 31, 2025
1
-17.9%
-3
+26.1%
-230.30
+13.2%
Feb 13, 2025
44 days after quarter end
Q1 FY2025
ended Dec 31, 2024
1
-2.3%
-3
-138.8%
-417.53
-24034.7%
Aug 8, 2024
39 days after quarter end
—
ended Jun 30, 2024
—
—
—
May 10, 2024
40 days after quarter end
—
ended Mar 31, 2024
—
—
—
Feb 8, 2024
39 days after quarter end
—
ended Dec 31, 2023
—
—
—
Dec 7, 2023
68 days after quarter end
—
ended Sep 30, 2023
—
—
—
Aug 10, 2023
41 days after quarter end
—
ended Jun 30, 2023
—
—
—

Company profile

Industry
Finance Services (SIC 6199)
Listed as
BNBX (OTC)
Fiscal year ends
September 30
Incorporated in
DE
Headquarters
Stony Brook, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
744452
Former names
APPLIED DNA SCIENCES INC (until Nov 10, 2025); PROHEALTH MEDICAL TECHNOLOGIES INC (until Dec 18, 2002); DCC ACQUISITION CORP (until May 4, 2001); DATALINK CAPITAL CORP/TX/ (until Feb 8, 1999)

Other Finance Services companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.